NCT07145333 2025-09-08Drug-SNPMedicine Invention Design, IncPhase 2/3 Active not recruiting600 enrolled
NCT05844150 2025-03-12A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLCBiotheus Inc.Phase 2 Active not recruiting50 enrolled
NCT05879068 2024-12-18A Study of PM8002 in Combination With Chemotherapy in Patients With SCLCBiotheus Inc.Phase 2 Active not recruiting99 enrolled